News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Members Vote Overwhelmingly For Bioinformatics Conference To Return To Stanford University

10/19/2005 5:09:00 PM

The Third Annual Computational Systems Bioinformatics (CSB) 2004 conference, sponsored by the IEEE Computer Society with support from HP, BioMed Central and a grant from the U.S. Department of Energy, will be held August 16-19, 2004 at Stanford University. A 70% majority of members overwhelmingly agree that this conference captures the sector’s technological advances, thus it is apropos that the conference remains in Silicon Valley. More than 600 top scientists from 35 countries come to exchange current research insights from 40 peered reviewed papers and 150 posters from genomics, proteomics, medical informatics and many more specialty areas. “Bioinformatics is one of the most important technological areas of our time – we are working to gain control over disease, aging, environmental degradation, preservation of species, and the general notion of wellness,” said Abraham Lempel, director of Computational BioScience Research for HP Labs. “CSB 2004 is an opportunity for all the leading minds and participating organizations to come together and pool our thoughts, theories and developments to keep us moving onto further discoveries, and HP is proud to participate in and sponsor such an important event in the field.” Keynote speakers such as Dr. Gene Myers, who was recently awarded the International Max Plank Research Prize for cutting edge research, sees the CSB 2004 conference as an important conference for developing a network to foster collaboration between academia and industry as well as an opportunity for researchers to identify potential collaborative opportunities. "The CSB conference brings the IEEE’s huge computer science membership to the table to learn about pressing real world biology problems,” said Dr. Gene Myers, a professor at the University of California, Berkeley and former VP of Informatics at Celera Genomics. “My own experience moving between academia and industry has strengthened my conviction that an emphasis on collaboration and technology transfer between these two communities can accelerate the pace of discoveries that will improve health and the human condition.” For complete program details and registration visit

Read at press release

comments powered by Disqus